These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2859870)

  • 41. Effects of the cardioselective beta-blocker metoprolol in angina pectoris. A subacute study with exercise tests.
    Keyriläinen O; Uustialo A
    Ann Clin Res; 1975 Dec; 7(6):433-41. PubMed ID: 2092
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-arrhythmic properties of the alpha-adrenoceptor blocking drug indoramin.
    James MA; Jones JV
    Br J Clin Pharmacol; 1991 Sep; 32(3):375-8. PubMed ID: 1685666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of L-carnitine on exercise tolerance in chronic stable angina: a multicenter, double-blind, randomized, placebo controlled crossover study.
    Cherchi A; Lai C; Angelino F; Trucco G; Caponnetto S; Mereto PE; Rosolen G; Manzoli U; Schiavoni G; Reale A
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):569-72. PubMed ID: 3905631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Labetalol therapy in patients with systemic hypertension and angina pectoris: effects of combined alpha and beta adrenoceptor blockade.
    Frishman WH; Strom JA; Kirschner M; Poland M; Klein N; Halprin S; LeJemtel TH; Kram M; Sonnenblick EH
    Am J Cardiol; 1981 Nov; 48(5):917-28. PubMed ID: 6118060
    [No Abstract]   [Full Text] [Related]  

  • 45. Effect of beta-adrenoceptor blockade on atrial natriuretic peptide levels during exercise in angina pectoris.
    Riley M; Elborn JS; Onuoha G; Erwin C; Shaw C; Khan MM; Stanford CF; Nicholls DP
    Br J Clin Pharmacol; 1993 Feb; 35(2):209-12. PubMed ID: 8095150
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short-term effects of captopril on exercise tolerance in patients with chronic stable angina pectoris and normal left ventricular function.
    Steffensen R; Grande P; Madsen JK; Rasmussen S; Haunsø S
    Cardiology; 1995; 86(6):445-50. PubMed ID: 7585753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antianginal effects of clonidine.
    Thomas MG; Quiroz AC; Rice JC; Sander GE; Giles TD
    J Cardiovasc Pharmacol; 1986; 8 Suppl 3():S69-75. PubMed ID: 2429117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Failure of thromboxane synthetase inhibition to improve exercise tolerance in patients with stable angina pectoris.
    Hendra T; Collins P; Penny W; Sheridan DJ
    Int J Cardiol; 1984 Mar; 5(3):382-5. PubMed ID: 6538553
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exercise tolerance in angina is improved by mivazerol--an alpha 2-adrenoceptor agonist.
    Wright RA; Decroly P; Kharkevitch T; Oliver MF
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):929-34. PubMed ID: 7912103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preliminary observations of chronic indoramin therapy in congestive heart failure.
    Leier CV; Huss P; Parrish D; Binkley PF; Unverferth DV
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S112-6. PubMed ID: 2423783
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trial of an alpha-adrenolytic drug (indoramin) for nocturnal enuresis.
    Shaffer D; Hedge B; Stephenson J
    Dev Med Child Neurol; 1978 Apr; 20(2):183-8. PubMed ID: 25217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alpha-adrenergic blockade for variant angina: a long-term, double-blind, randomized trial.
    Winniford MD; Filipchuk N; Hillis LD
    Circulation; 1983 Jun; 67(6):1185-8. PubMed ID: 6133637
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usefulness of nicardipine as monotherapy for chronic, stable angina.
    Sklar J; Dennish GW; Glode J; Wyskoarko NP; Giles T; Freedman D; Buhite SG; Koretz SH; Roe RL
    Am J Cardiol; 1989 May; 63(17):1203-7. PubMed ID: 2711990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of plasma free fatty acid lowering on exercise tolerance and ST segment depression in patients with angina pectoris.
    Loogna E; Kaijser L; Carlson LA
    Acta Med Scand; 1979; 206(5):371-4. PubMed ID: 393081
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of beta-adrenergic blockade with alprenolol on ST-segment depression and circulatory dynamics during exercise in patients with effort angina.
    Bailey IK; Anderson SD; Rozea PJ; Bernstein L; Nyberg G; Korner PI
    Am Heart J; 1976 Oct; 92(4):416-26. PubMed ID: 961582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of theophylline on exercise-induced myocardial ischaemia.
    Crea F; Pupita G; Galassi AR; el Tamimi H; Kaski JC; Davies GJ; Maseri A
    Lancet; 1989 Apr; 1(8640):683-6. PubMed ID: 2564505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical cardiac electrophysiological assessment of indoramin.
    Butrous GS; Camm AJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S137-43. PubMed ID: 2423787
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antihypertensive therapy in the Federal Republic of Germany: clinical practice experience with indoramin (Wydora).
    Grube E; Giesing M
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S43-7. PubMed ID: 2423796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effect of a neuropeptide Y Y1 receptor antagonist in patients with angina pectoris.
    Gullestad L; Bjurø T; Aaberge L; Apelland T; Skårdal R; Kjekshus E; Nordlander M; Ablad B; Pernow J
    Eur Heart J; 2003 Jun; 24(12):1120-7. PubMed ID: 12804926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indoramin in the treatment of hypertension: a placebo controlled trial.
    Ramirez J
    Curr Med Res Opin; 1976; 4(3):177-84. PubMed ID: 780059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.